Godavari Drugs Ltd

NSE: GODAVARI · BSE: 530317 · Pharmaceuticals & Biotechnology · 3 announcements

Share price: ₹125.18
Market cap: ₹126.8 Cr
Revenue (annual): ₹105.8 Cr
Net profit (annual): ₹4.09 Cr
P/E (TTM): 30.5×Sector 50.4×
Promoter holding: 40.23%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements

25 Sep 2026 16:43 IST BSE

Annual General Meeting

Godavari Drugs Annual General Meeting

Godavari Drugs held its 38th Annual General Meeting on September 25, 2026, via video conferencing. Shareholders approved financial statements, director re-appointment, and object clause alteration.

Read the filing ↗

14 Aug 2026 12:55 IST BSE

Financial Results

Godavari Drugs Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 10.0% YoY

Godavari Drugs Ltd reported revenue from operations of ₹28 Cr (+17.6% YoY) and net profit of ₹1.1 Cr (+10.0% YoY) for Q1 FY27.

Key figure: Net profit ₹1.1 Cr · +10.0% YoY

Open full results → Read the filing ↗

27 May 2026 16:48 IST BSE

Financial Results

Godavari Drugs Q4 FY26 Results: Net Profit ₹1.3 Cr, Up 44.4% YoY

Godavari Drugs Ltd reported revenue from operations of ₹33.2 Cr (+30.2% YoY) and net profit of ₹1.3 Cr (+44.4% YoY) for Q4 FY26.

Key figure: Net profit ₹1.3 Cr · +44.4% YoY

Open full results → Read the filing ↗